Pleomorphic myxoid liposarcoma in an adolescent with Li–Fraumeni syndrome (original) (raw)

References

  1. Coffin CM, Alaggio R (2012) Adipose and myxoid tumors of childhood and adolescence. Pediatr Dev Pathol 15(1 Suppl):239–254. doi:10.2350/10-05-0836-PB.1
    Article PubMed Google Scholar
  2. Shmookler BM, Enzinger FM (1983) Liposarcoma occurring in children. An analysis of 17 cases and review of the literature. Cancer 52(3):567–574
    Article CAS PubMed Google Scholar
  3. Castleberry RP, Kelly DR, Wilson ER, Cain WS, Salter MR (1984) Childhood liposarcoma. Report of a case and review of the literature. Cancer 54(3):579–584
    Article CAS PubMed Google Scholar
  4. La Quaglia MP, Spiro SA, Ghavimi F, Hajdu SI, Meyers P, Exelby PR (1993) Liposarcoma in patients younger than or equal to 22 years of age. Cancer 72(10):3114–3119
    Article CAS PubMed Google Scholar
  5. Ferrari A, Casanova M, Spreafico F, Luksch R, Terenziani M, Cefalo G, Massimino M, Gandola L, Navarria P, Fossati-Bellani F (1999) Childhood liposarcoma: a single-institutional twenty-year experience. Pediatr Hematol Oncol 16(5):415–421. doi:10.1080/088800199276967
    Article CAS PubMed Google Scholar
  6. Huh WW, Yuen C, Munsell M, Hayes-Jordan A, Lazar AJ, Patel S, Wang WL, Barahmani N, Okcu MF, Hicks J, Debelenko L, Spunt SL (2011) Liposarcoma in children and young adults: a multi-institutional experience. Pediatr Blood Cancer 57(7):1142–1146. doi:10.1002/pbc.23095
    Article PubMed PubMed Central Google Scholar
  7. Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL (2009) Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol 33(5):645–658. doi:10.1097/PAS.0b013e3181963c9c
    Article PubMed Google Scholar
  8. Kauffman SL, Stout AP (1959) Lipoblastic tumors of children. Cancer 12:912–925
    Article CAS PubMed Google Scholar
  9. Creytens D, van Gorp J, Ferdinande L, Van Roy N, Libbrecht L (2014) Array-based comparative genomic hybridization analysis of a pleomorphic myxoid liposarcoma. J Clin Pathol 67(9):834–835. doi:10.1136/jclinpath-2014-202420
    Article PubMed Google Scholar
  10. Hofvander J, Jo VY, Ghanei I, Gisselsson D, Martensson E, Mertens F (2016) Comprehensive genetic analysis of a paediatric pleomorphic myxoid liposarcoma reveals near-haploidization and loss of the RB1 gene. Histopathology 69(1):141–147. doi:10.1111/his.12913
    Article PubMed Google Scholar
  11. Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA et al (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250(4985):1233–1238
    Article CAS PubMed Google Scholar
  12. Srivastava S, Zou ZQ, Pirollo K, Blattner W, Chang EH (1990) Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature 348(6303):747–749. doi:10.1038/348747a0
    Article CAS PubMed Google Scholar
  13. Schneider K, Zelley K, Nichols KE, Garber J (1993) Li-Fraumeni syndrome. In: Pagon RA, Adam MP, Ardinger HH et al (eds) GeneReviews(R), Seattle (WA)
  14. Lustbader ED, Williams WR, Bondy ML, Strom S, Strong LC (1992) Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am J Hum Genet 51(2):344–356
    CAS PubMed PubMed Central Google Scholar
  15. Kamihara J, Rana HQ, Garber JE (2014) Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome. Hum Mutat 35(6):654–662. doi:10.1002/humu.22559
    Article CAS PubMed Google Scholar
  16. Ognjanovic S, Olivier M, Bergemann TL, Hainaut P (2012) Sarcomas in TP53 germline mutation carriers: a review of the IARC TP53 database. Cancer 118(5):1387–1396. doi:10.1002/cncr.26390
    Article CAS PubMed Google Scholar
  17. Li FP, Fraumeni JF Jr, Mulvihill JJ, Blattner WA, Dreyfus MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48(18):5358–5362
    CAS PubMed Google Scholar
  18. Chompret A, Abel A, Stoppa-Lyonnet D, Brugieres L, Pages S, Feunteun J, Bonaiti-Pellie C (2001) Sensitivity and predictive value of criteria for p53 germline mutation screening. J Med Genet 38(1):43–47
    Article CAS PubMed PubMed Central Google Scholar
  19. Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, Caron O, Bressac-de Paillerets B, Berthet P, Dugast C, Bonaiti-Pellie C, Stoppa-Lyonnet D, Frebourg T (2009) 2009 version of the Chompret criteria for Li Fraumeni syndrome. J Clin Oncol 27(26):e108–109. doi:10.1200/JCO.2009.22.7967 (author reply e110)
    Article PubMed Google Scholar
  20. Gonzalez KD, Noltner KA, Buzin CH, Gu D, Wen-Fong CY, Nguyen VQ, Han JH, Lowstuter K, Longmate J, Sommer SS, Weitzel JN (2009) Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 27(8):1250–1256. doi:10.1200/JCO.2008.16.6959
    Article CAS PubMed Google Scholar
  21. Ruijs MW, Verhoef S, Rookus MA, Pruntel R, van der Hout AH, Hogervorst FB, Kluijt I, Sijmons RH, Aalfs CM, Wagner A, Ausems MG, Hoogerbrugge N, van Asperen CJ, Gomez Garcia EB, Meijers-Heijboer H, Ten Kate LP, Menko FH, van ‘t Veer LJ (2010) TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. J Med Genet 47(6):421–428. doi:10.1136/jmg.2009.073429
    Article CAS PubMed Google Scholar
  22. Evans DG, Birch JM, Ramsden RT, Sharif S, Baser ME (2006) Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes. J Med Genet 43(4):289–294. doi:10.1136/jmg.2005.036319
    Article CAS PubMed Google Scholar
  23. Cohen RJ, Curtis RE, Inskip PD, Fraumeni JF Jr (2005) The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 103(11):2391–2396. doi:10.1002/cncr.21040
    Article PubMed Google Scholar
  24. Villani A, Tabori U, Schiffman J, Shlien A, Beyene J, Druker H, Novokmet A, Finlay J, Malkin D (2011) Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study. Lancet Oncol 12(6):559–567. doi:10.1016/s1470-2045(11)70119-x
    Article CAS PubMed Google Scholar

Download references